alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                  EXHIBIT 99.1

                  CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Front Range Capital Corporation (the
"Company") on Form 10-KSB for the period ending March 31, 2003, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
William A. Mitchell, Jr., Chief Executive Officer and President of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

                                           /s/ William A. Mitchell, Jr.
                                           -------------------------------------
                                           William A. Mitchell, Jr.
                                           Chief Executive Officer and President

May 13, 2003

A signed original of this written statement required by Section 906 has been
provided to Front Range Capital Corporation and will be retained by Front Range
Capital Corporation and furnished to the Securities and Exchange Commission or
its staff upon request.
### OFFICE OF THE ATTORNEY GENERAL OF TEXAS AUSTIN **GROVER SELLERS**  **ATTORNEY GENERAL**  

### Honoxabls

Ikmm D. Eok County Auditor 

### FsyetteGouoty 

### LaCSrangs,

T6xas 

### Dear Slrr.- i : ’

. lXanorable
‘

_’ The warden or other pweox, Ocauuduotin

l x o o u tl o n



### ahall<B allowed

therefor the



### twtmty-f

f vs 

### dollas to **bs** 

### aid **by** 

### the oountyla whiabjw%g- : aent of axeoutrm was rendered, **and** 

### the aa%alef sioaerscourto? 8udh county#ball approve auoh aookut IS& order It paid out of thu @mm11 funds of the county, 

### upon the oortitlo0te of.ths distrlat alsk of thq 

### oouutg, ahavbg 

### tha!.aaturn by 

### 'the w0 r ge t3 

### or t he ,ded h 

### *arrant, w it h

l x o o u ti o n

or s e nt 6 n o e n d o ~ r ed t h 6 r 00 n.a :
### THE THIRTEENTH COURT OF APPEALS

13

- 14

- 00050

- CR

Adrien "Bull" Shermane Thomas

v. The State of Texas

On Appeal from the 24th District Court of DeWitt County , Texas Trial Cause No. 05

- 04

- 10,130

JUDGMENT THE THIRTEENTH COURT OF APPEALS, having conside red this cause on appeal, concludes that the judgment of the trial court should be AFFIRMED . The Court orders the judgment of the trial court AFFIRMED

. We further order this decision certified below for observance. September 18 , 2014
##### 



EXHIBIT 12 Republic Bancorp Inc.
Calculations of Ratios of Earnings to Combined Fixed Charges Three Months Ended
    
    Six Months Ended(in thousands)
    
    June 30,
    
    June 30,2004
    
    2003
    
    2004
    
    2003Including Interest on Deposits:Fixed charges:Total interest expense
    
    $
    31,795
    
    
    $
    30,977
    
    
    $
    63,735
    
    
    $
    62,202Interest portion of rent expense
    
    
    183
    
    
    
    185
    
    
    
    377
    
    
    
    381Fixed charges including interest on deposits
    
    $
    31,978
    
    
    $
    31,162
    
    
    $
    64,112
    
    
    $
    62,583Earnings:Net income
    
    $
    16,368
    
    
    $
    15,158
    
    
    $
    32,667
    
    
    $
    30,311Income taxes
    
    
    6,968
    
    
    
    6,503
    
    
    
    13,840
    
    
    
    13,354Fixed charges, as above
    
    
    31,978
    
    
    
    31,162
    
    
    
    64,112
    
    
    
    62,583Earnings for purposes of calculation
    
    $
    55,314
    
    
    $
    52,823
    
    
    $
    110,619
    
    
    $
    106,248Ratio of earnings to combined fixed charges including
interest on deposits
    
    
    1.73
    x
    
    
    1.70
    x
    
    
    1.73
    x
    
    
    1.70
    xExcluding Interest on Deposits:Fixed charges:Total interest expense excluding interest on deposits
    
    $
    19,128
    
    
    $
    16,545
    
    
    $
    38,031
    
    
    $
    32,276Interest portion of rent expense
    
    
    183
    
    
    
    185
    
    
    
    377
    
    
    
    381Fixed charges excluding interest on deposits
    
    $
    19,311
    
    
    $
    16,730
    
    
    $
    38,408
    
    
    $
    32,657Earnings:Net income
    
    $
    16,368
    
    
    $
    15,158
    
    
    $
    32,667
    
    
    $
    30,311Income taxes
    
    
    6,968
    
    
    
    6,503
    
    
    
    13,840
    
    
    
    13,354Fixed charges, as above
    
    
    19,311
    
    
    
    16,730
    
    
    
    38,408
    
    
    
    32,657Earnings for purposes of calculation
    
    $
    42,647
    
    
    $
    38,391
    
    
    $
    84,915
    
    
    $
    76,322Ratio of earnings to combined fixed charges excluding
interest on deposits
    
    
    2.21
    x
    
    
    2.29
    x
    
    
    2.21
    x
    
    
    2.34
    x
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                           6,901
<SECURITIES>                                     2,002
<RECEIVABLES>                                   28,603
<ALLOWANCES>                                   (1,215)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                41,092
<PP&E>                                          15,623
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  67,155
<CURRENT-LIABILITIES>                           11,727
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      55,141
<TOTAL-LIABILITY-AND-EQUITY>                    67,155
<SALES>                                              0
<TOTAL-REVENUES>                                60,058
<CGS>                                           29,936
<TOTAL-COSTS>                                   56,671
<OTHER-EXPENSES>                                 (356)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  3,743
<INCOME-TAX>                                     1,498
<INCOME-CONTINUING>                              2,245
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,245
<EPS-BASIC>                                       0.20
<EPS-DILUTED>                                     0.20


</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              OCT-31-2000
<PERIOD-START>                                 NOV-01-1999
<PERIOD-END>                                   OCT-31-2000
<CASH>                                             153,844
<SECURITIES>                                             0
<RECEIVABLES>                                    2,267,474
<ALLOWANCES>                                       200,510
<INVENTORY>                                      1,466,050
<CURRENT-ASSETS>                                 3,893,995
<PP&E>                                           3,987,046
<DEPRECIATION>                                   2,161,398
<TOTAL-ASSETS>                                   5,997,477
<CURRENT-LIABILITIES>                            2,831,807
<BONDS>                                          3,101,239
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                             4,000
<OTHER-SE>                                         221,144
<TOTAL-LIABILITY-AND-EQUITY>                     5,997,477
<SALES>                                         20,097,548
<TOTAL-REVENUES>                                20,097,548
<CGS>                                           16,673,790
<TOTAL-COSTS>                                   16,673,790
<OTHER-EXPENSES>                                 2,603,538
<LOSS-PROVISION>                                    44,091
<INTEREST-EXPENSE>                                 406,859
<INCOME-PRETAX>                                    400,334
<INCOME-TAX>                                       119,000
<INCOME-CONTINUING>                                281,334
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                       281,334
<EPS-BASIC>                                            .07
<EPS-DILUTED>                                            0



</TABLE>
#### § 58.51 Specimen and data storage facilities.

Space shall be provided for archives, limited to access by authorized personnel only, for the storage and retrieval of all raw data and specimens from completed studies.
§ 582.1666 Propylene glycol. ( a ) *Product.* Propylene glycol.
( b ) *Conditions of use.* This substance is generally recognized as safe (except in cat food) when used in accordance with good manufacturing or feeding practice.
[41 FR 38657, Sept. 10, 1976, as amended at 61 FR 19544, May 2, 1996]
Exhibit 23

 

**Consentof Independent Registered Public Accounting Firm**

 

We consent to theincorporation by reference in the Registration Statements on Form S-8 (No. 333-155875and 333-130041)****of Retractable Technologies, Inc.of our report dated March 31, 2010, except for Note 2, (SUMMARY OFSIGNIFICANT ACCOUNTING POLICIES, Long-lived assets) as to which the date isApril 7, 2010, relating to our audit of the financial statements and financialstatement schedule, which appear in this Annual Report on Form 10-K/A ofRetractable Technologies, Inc. for the year ended December 31, 2009.

 
|   | /s/ CF & Co.,  L.L.P. |   |
|--------|--------------------------------|--------|
|   | CF & Co.,  L.L.P.     |   |

 

Dallas, Texas

April7, 2010

 

----
§ 501.8 Labeling of animal food with number of servings. ( a ) The label of any package of a food which bears a representation as to the number of servings contained in such package shall bear in immediate conjunction with such statement, and in the same size type as is used for such statement, a statement of the net quantity (in terms of weight, measure, or numerical count) of each such serving; however, such statement may be expressed in terms that differ from the terms used in the required statement of net quantity of contents (for example, cupfuls, tablespoonfuls, etc.) when such differing term is common to cookery and describes a constant quantity. Such statement may not be misleading in any particular. A statement of the number of units in a package is not in itself a statement of the number of servings.
( b ) If there exists a voluntary product standard promulgated pursuant to the procedures found in 15 CFR part 10 by the Department of Commerce, quantitatively defining the meaning of the term *serving* with respect to a particular food, then any label representation as to the number of servings in such packaged food shall correspond with such quantitative definition. (Copies of published standards are available upon request from the National Bureau of Standards, Department of Commerce, Washington, DC 20234.)
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.1299 Ferric ferrocyanide. ( a ) *Identity.* ( 1 ) The color additive ferric ferrocyanide is a ferric hexacyanoferrate pigment characterized by the structual formula Fe4[Fe(CN)6]3·XH2O, which may contain small amounts of ferric sodium ferrocyanide and ferric potassium ferrocyanide.
( 2 ) Color additive mixtures for drug use made with ferric ferrocyanide may contain only those diluents listed in this subpart as safe and suitable for use in color additive mixtures for coloring drugs.
( b ) *Specifications.* Ferric ferrocyanide shall conform to the following specifications and shall be free from impurities other than those named to the extent that such impurities may be avoided by good manufacturing practice: Water soluble cyanide, not more than 10 parts per million. Lead (as Pb), not more than 20 parts per million. Arsenic (as As), not more than 3 parts per million. Nickel (as Ni), not more than 200 parts per million. Cobalt (as Co), not more than 200 parts per million. Mercury (as Hg), not more than 1 part per million. Oxalic acid, not more than 0.1 percent. Water soluble matter, not more than 3 percent. Volatile matter, not more than 10 percent. Total iron (as Fe corrected for volatile matter), not less than 37 percent and not more than 45 percent.
( c ) *Uses and restrictions.* Ferric ferrocyanide may be safely used in amounts consistent with good manufacturing practice to color externally applied drugs including those intended for use in the area of the eye.
( d ) *Labeling requirements.* The label of the color additive and of any mixtures prepared therefrom intended solely or in part for coloring purposes shall conform to the requirements of § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from certification requirements of section 721(c) of the act.
[43 FR 54235, Nov. 21, 1978]
###### Editorial Note on Part 172

#### Editorial Note:

Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

#### § 172.115 BHT.

The food additive BHT (butylated hydroxytoluene), alone or in combination with other antioxidants permitted in this subpart B may be safely used in or on specified foods, as follows:

(a) The BHT meets the following specification: Assay (total BHT) 99 percent minimum.

(b) The BHT is used alone or in combination with BHA, as an antioxidant in foods, as follows:

| Food | Limitations (total BHA and BHT) parts per million |
| --- | --- |
| Dehydrated potato shreds | 50 |
| Dry breakfast cereals | 50 |
| Emulsion stabilizers for shortenings | 200 |
| Potato flakes | 50 |
| Potato granules | 10 |
| Sweetpotato flakes | 50 |

(c) To assure safe use of the additive:

(1) The label of any market package of the additive shall bear, in addition to the other information required by the Act, the name of the additive.

(2) When the additive is marketed in a suitable carrier, in addition to meeting the requirement of paragraph (c)(1) of this section, the label shall declare the percentage of the additive in the mixture.
PRINCETON BROWN

, Appellant,

v.

STATE OF FLORIDA, JULIE L. JONES, SECRETARY, FLORIDA DEPARTMENT OF CORRECTIONS

, Appellee s

. IN THE DISTRICT COURT OF APPEAL FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO FILE MOTION FOR REHEARING AND DISPOSITION THEREOF IF FILED

CASE NO. 1D 14

- 1356

_____________________________/

Opinion filed January 12, 2015.

An appeal from the Circuit Court for Taylor County

. Gregory S. Parker , Judge

. Princeton Brown, pro se , Appellant.

Pamela Jo Bondi, Attorney General, and Anne C. Conley, Tallahassee , for Appellee s

.

PER CURIAM.

AFFIRMED.

LEWIS

, C.J., CLARK

, and MARSTILLER

, J J

. , CONCUR.
§ 524.1580b Nitrofurazone soluble powder. ( a ) *Specifications.* The drug contains 0.2 percent nitrofurazone in a water-soluble base.
( b ) *Sponsor.* See Nos. 059051 and 069043 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* Apply several times daily to the lesion or affected area from the plastic squeeze bottle.
( 2 ) *Indications for use.* For prevention or treatment of surface bacterial infections of wounds, burns, skin ulcers, and abscesses after incision.
( 3 ) *Limitations.* In case of deep or puncture wounds or serious burns, use only as recommended by veterinarian. If redness, irritation, or swelling persists or increases, discontinue use; consult veterinarian. For use only on dogs, cats, and horses (not for food use).
[45 FR 43402, June 27, 1980, as amended at 47 FR 43368, Oct. 1, 1982; 48 FR 28984, June 24, 1983; 53 FR 40728, Oct. 18, 1988; 54 FR 30542, July 21, 1989; 56 FR 50653, Oct. 8, 1991; 59 FR 33197, June 28, 1994; 60 FR 55659, Nov. 2, 1995; 62 FR 35077, June 30, 1997; 76 FR 17778, Mar. 31, 2011; 78 FR 21060, Apr. 9, 2013. Redesignated at 79 FR 10971, Feb. 27, 2014, as amended at 79 FR 64117, Oct. 28, 2014; 83 FR 48947, Sept. 28, 2018]
§ 573.1010 Xanthan gum. The food additive xanthan gum may be safely used in animal feed as follows: ( a ) The food additive is xanthan gum as defined in § 172.695 of this chapter and meets all of the specifications thereof.
( b ) It is used or intended for use as a stabilizer, emulsifier, thickener, suspending agent, or bodying agent in animal feed as follows: ( 1 ) In calf milk replacers at a maximum use level of 0.1 percent, as fed.
( 2 ) In liquid feed supplements for ruminant animals at a maximum use level of 0.25 percent (5 pounds per ton).
( c ) To assure safe use of the additive: ( 1 ) The label of its container shall bear, in addition to other information required by the act, the name of the additive.
( 2 ) The label or labeling of the additive container shall bear adequate directions for use.
[49 FR 44630, Nov. 8, 1984]
**Exhibit 31 (b)**I, Gary Jones certify that: 1. I have reviewed this quarterly report on Form 10-Q of Northland Cable PropertiesSeven Limited Partnership;  2. Based on my knowledge, this quarterly report does not contain any untrue statementof a material fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this quarterly report;  3. Based on my knowledge, the financial statements, and other financial informationincluded in this quarterly report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this quarterly report;  4. The registrant’s other certifying officer and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) for the registrant and we have: a) Designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which thisquarterly report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions aboutthe effectiveness of the disclosure controls and procedures, as of the endof the period covered by this report based on such evaluation; and  c) Disclosed in this report any change in the registrant’sinternal controls over financial reporting that occurred during theregistrant’s most recent fiscal quarter that has materially affected, or isreasonably likely to affect, the registrant’s internal controls overfinancial reporting; and 5. The registrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal controls over financial reporting, to the registrant’sauditors and board of directors: a) All significant deficiencies and material weaknesses in thedesign or operation of internal controls over financial reporting, whichare reasonably likely to adversely affect the registrant’s ability torecord, process, summarize and report financial information; and  b) Any fraud, whether or not material, that involvesmanagement or other employees who have a significant role in theregistrant’s internal controls over financial reporting.**Date: 5-14-07**     /s/
§ 700.15 Use of certain halogenated salicylanilides as ingredients in cosmetic products. ( a ) Halogenated salicylanilides (tribromsalan (TBS,3,4′,5-tribromosalicylanilide), dibromsalan (DBS,4′5-dibromosalicylanilide), metabromsalan (MBS, 3,5-dibromosalicylanilide) and 3,3′,4,5′-tetrachlorosalicylanilide (TCSA)) have been used as antimicrobial agents for a variety of purposes in cosmetic products. These halogenated salicylanilides are potent photosensitizers and cross-sensitizers and can cause disabling skin disorders. In some instances, the photosensitization may persist for prolonged periods as a severe reaction without further exposure to these chemicals. Safer alternative antimicrobial agents are available.
( b ) These halogenated salicylanilides are deleterious substances which render any cosmetic that contains them injurious to users. Therefore, any cosmetic product that contains such a halogenated salicylanilide as an ingredient at any level for any purpose is deemed to be adulterated under section 601(a) of the Federal Food, Drug, and Cosmetic Act.
( c ) Any cosmetic product containing these halogenated salicylanilides as an ingredient that is initially introduced into interstate commerce after December 1, 1975, that is not in compliance with this section is subject to regulatory action.
[40 FR 50531, Oct. 30, 1975]
EXHIBIT 32.2
                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002


In connection  with the  quarterly  report of Avitar,  Inc.  (the  "Company") on
Form10-QSB/A  for the  period  ending  December  31,  2004  as  filed  with  the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Jay C.
Leatherman,  Jr., Chief Financial Officer of the Company certify, pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, to my knowledge, that:


     (1) The Report  fully  complies  with the  requirements  of  Section  13(a)
or15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


Date: February 10, 2006


                                        /s/ Jay C. Leatherman, Jr.
                                        -------------------------
                                        Jay C. Leatherman, Jr.
                                        Chief Financial Officer (Principal
                                        Financial and Accounting Officer),
                                        Secretary